Showing results (21-30 of 622) with videos related to

Sort By:
Pageof 63
Pathologie-Biologie|October 14, 1998
[Antisense oligonucleotides: a new therapeutic approach]P Guinot, J Temsamani
The Journal of Biological Chemistry|October 25, 1991
The U2 small nuclear ribonucleoprotein particle associates with nuclear factors in a pre-mRNA independent reactionJ Temsamani, M Rhoadhouse, T Pederson
Expert Opinion on Investigational Drugs|July 5, 2005
Antisense approach for the treatment of cytomegalovirus infectionJ Temsamani, G S Pari, P Guinot
Biochemistry|May 1, 2001
Translocation of the pAntp peptide and its amphipathic analogue AP-2ALG Drin, H Déméné, J Temsamani, et al.
Expert Opinion on Biological Therapy|December 1, 2001
Vector-mediated drug delivery to the brainJ Temsamani, C Rousselle, A R Rees, et al.
Nucleic Acids Research|January 25, 1990
Interplay between U2 snRNP and 3' splice factor(s) for branch point selection on human beta-globin pre-mRNAC Alibert, J Tazi, J Temsamani, et al.
European Journal of Biochemistry|March 7, 2001
Physico-chemical requirements for cellular uptake of pAntp peptide. Role of lipid-binding affinityG Drin, M Mazel, P Clair, et al.
Trends in Biotechnology|October 1, 1996
Antisense oligonucleotides: towards clinical trialsS Agrawal
Trends in Biotechnology|May 1, 1992
Antisense oligonucleotides as antiviral agentsS Agrawal
Pageof 63